Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interface keratitis following endothelial keratoplasty.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2026
Same author

Trends in Patient-Surgeon Sex Concordance and Surgical Volume in Cataract Surgery: A 14-Year Retrospective Cohort Study.

American journal of ophthalmology·2026
Same author

Long-Term Graft Survival and Visual Outcomes in Deep Anterior Lamellar Keratoplasty (DALK): A Narrative Review.

Journal of ophthalmology·2026
Same author

Estrogen-dependent Cancers in Female Patients With Fuchs Endothelial Corneal Dystrophy.

Cornea·2025
Same author

Delphi-Based Global Consensus on Fuchs Endothelial Corneal Dystrophy. An Endothelial Keratoplasty Learners Group Initiative.

American journal of ophthalmology·2025
Same author

Concurrent Descemet Stripping Only With Excision of Iris Pigment Epithelial Cysts.

Cornea·2025

Related Experiment Video

Updated: Jun 28, 2025

Characterization of Blood Outgrowth Endothelial Cells BOEC from Porcine Peripheral Blood
08:02

Characterization of Blood Outgrowth Endothelial Cells BOEC from Porcine Peripheral Blood

Published on: January 6, 2022

1.7K

Current state of endothelial cell therapy.

Ellen H Koo1

  • 1Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida, USA.

Current Opinion in Ophthalmology
|April 11, 2024
PubMed
Summary

Endothelial cell therapy shows promise for corneal edema treatment. Ongoing human trials with injected human corneal endothelial cells (HCECs) demonstrate favorable safety and efficacy, suggesting future feasibility.

More Related Videos

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

11.2K
Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood
13:46

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Published on: April 13, 2012

16.3K

Related Experiment Videos

Last Updated: Jun 28, 2025

Characterization of Blood Outgrowth Endothelial Cells BOEC from Porcine Peripheral Blood
08:02

Characterization of Blood Outgrowth Endothelial Cells BOEC from Porcine Peripheral Blood

Published on: January 6, 2022

1.7K
Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

11.2K
Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood
13:46

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Published on: April 13, 2012

16.3K

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Corneal edema and dysfunction represent significant challenges in ophthalmic care.
  • Endothelial cell therapy is an emerging treatment modality gaining considerable attention.
  • Current treatments for corneal endothelial dysfunction have limitations.

Purpose of the Study:

  • To review the background and current research on endothelial cell therapy for corneal edema.
  • To summarize emerging treatment modalities in this field.
  • To provide an overview of the translational advancements and clinical trial progress.

Main Methods:

  • This is a review article, synthesizing existing research and clinical data.
  • Focus on translational research and refinements in cell therapy protocols.
  • Analysis of ongoing human clinical trials for injected human corneal endothelial cells (HCECs).

Main Results:

  • Significant advancements in translational research for endothelial cell therapy.
  • Refined treatment protocols are enhancing cell therapy efficacy.
  • Early human clinical trials of injected HCECs show promising safety and efficacy.

Conclusions:

  • Efficient delivery of HCECs for corneal edema is becoming feasible.
  • Ongoing clinical trials are highly anticipated for further validation.
  • Adjunct therapies, including pharmacological agents and surgical techniques like descemetorhexis, will complement cell therapy.